45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
11,353
Insurances with rates
3
CPT / HCPCS codes
9,755
Most expensive procedures (gross)
J2326
$446,250
nusinersen per 0.1 mg
Gross
$892,500
J9347
$104,296
tremelimumab-actl per 1 mg
Gross
$208,591
J9210
$91,516
emapalumab-lzsg per 1 mg
Gross
$183,033
J9266
$78,074
pegaspargase per 1 eacht
Gross
$156,148
33262
$64,073
HC Rem/Repl Aicd, 1 Lead System
Gross
$128,146
33263
$64,073
HC Rem/Repl Aicd, 2 Lead System
Gross
$128,146
33264
$64,073
HC Rem/Repl Aicd, 3+ Lead System
Gross
$128,146
33240
$59,472
HC Insert Single Card/Def
Gross
$118,943
33230
$56,640
Insert Dual Card/Def
Gross
$113,279
33249
$53,774
HC Ins/Rplcmt Perm Dfb W/Trnsvns Lds 1/Dual Chmbr
Gross
$107,547
J2350
$52,015
ocrelizumab per 1 mg
Gross
$104,030
C1721
$51,976
DEFIB PROTECTA DR D334DRG DEVICE
Gross
$103,951
J9281
$47,586
mitoMYcin 40 mg x 2 kit 1 each KIT
Gross
$95,172
J9309
$46,901
polatuzumab vedotin-piiq per 1 mg
Gross
$93,802
J3241
$45,408
teprotumumab per 10 mg
Gross
$90,816
J9334
$40,543
efgartigimod-hyaluronidas-qvfc 1,008 mg-11,200 unit/5.6 mL solution 5.6 mL Vial
Gross
$81,086
J9298
$38,863
nivolumab-relatlimab-rmbw 240-80 mg/20 mL solution 20 mL Vial
Gross
$77,727
J9307
$38,652
pralatrexate per 1 mg
Gross
$77,305
C1767
$37,947
HC Generator, Neurostimulator (Implantable), Nonrechargeable (Sentiva)
Gross
$75,893
33225
$37,845
HC Left Ventricular Lead Insertion (With Pacer/Aicd Insrt)
Gross
$75,690
37227
$37,803
HC Femoral Atherectomy Inc Stent Placement
Gross
$75,605
J9026
$37,800
tarlatamab per 1 mg
Gross
$75,600
J3357
$36,731
ustekinumab per 1 mg
Gross
$73,462
J1628
$36,707
guselkumab per 1 mg
Gross
$73,415
93656
$36,103
HC Ep Ablation of Af by Pvi W/ Transseptal and Ep Evaluation
Gross
$72,205
J9217
$32,453
leuprolide 45 mg syringe kit 1 each KIT
Gross
$64,905
93654
$31,965
Comp Eps W/Ablation Vt Focus
Gross
$63,930
J9042
$31,943
brentuximab vedotin per 1 mg
Gross
$63,886
J9043
$30,556
cabazitaxel per 1 mg
Gross
$61,113
J9272
$30,316
dostarlimab-gxly 50 mg/mL solution 10 mL Vial
Gross
$60,633
36906
$29,750
HC Perc Thrombectomy & Stent(S) in Periph Segment Av Graft, Incl Pta &
Gross
$59,500
J9022
$29,205
atezolizumab per 10 mg
Gross
$58,410
0795T
$28,415
HC Tcat Ins Perm Dual Ldls Pm Cmpl Sys
Gross
$56,829
0801T
$28,158
HC Ep-Dual Leadless Pacemaker Removal & Replacement
Gross
$56,315
J2329
$27,997
ublituximab-xiiy per 1 mg
Gross
$55,994
J9119
$27,531
cemiplimab-rwlc per 1 mg
Gross
$55,062
37231
$27,490
Tib/per Revasc Stent & Ather
Gross
$54,979
0238T
$27,490
HC Trluml Perip Athrc Iliac Art
Gross
$54,979
J2327
$26,793
risankizumab per 1 mg
Gross
$53,585
J1744
$26,687
icatibant per 1 mg
Gross
$53,374
J9144
$26,641
daratumumab, hyaluronidase per 10 mg
Gross
$53,282
J3055
$26,107
talquetamab-tgvs per 0.25 mg
Gross
$52,214
33274
$25,627
HC Leadless Pacemaker
Gross
$51,253
C9765
$25,571
HC Revasc of Lower Extremity With Ivl/Pta/Stent
Gross
$51,141
C9766
$25,571
HC Revasc Ivl/Athrec/Pta
Gross
$51,141
C9767
$25,571
HC Revasc Ivl/ Athrec/Pta/Stent
Gross
$51,141
C9773
$25,571
HC Revasc Tib/Peroneal Ivl/Pta/Stent
Gross
$51,141
C9774
$25,571
HC Revasc Tib/Peroneal Ivl/Athrec/Pta
Gross
$51,141
C9775
$25,571
HC Revasc Tib/Peroneal Ivl/Athrec/Stent
Gross
$51,141
33206
$25,105
Atrial Ld W/Pac Inse/Repl
Gross
$50,210
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2326 | nusinersen per 0.1 mg | $892,500 | $446,250 | — | — | 5 |
| J9347 | tremelimumab-actl per 1 mg | $208,591 | $104,296 | — | — | 5 |
| J9210 | emapalumab-lzsg per 1 mg | $183,033 | $91,516 | — | — | 10 |
| J9266 | pegaspargase per 1 eacht | $156,148 | $78,074 | — | — | 5 |
| 33262 | HC Rem/Repl Aicd, 1 Lead System | $128,146 | $64,073 | — | — | 5 |
| 33263 | HC Rem/Repl Aicd, 2 Lead System | $128,146 | $64,073 | — | — | 5 |
| 33264 | HC Rem/Repl Aicd, 3+ Lead System | $128,146 | $64,073 | — | — | 5 |
| 33240 | HC Insert Single Card/Def | $118,943 | $59,472 | — | — | 5 |
| 33230 | Insert Dual Card/Def | $113,279 | $56,640 | — | — | 5 |
| 33249 | HC Ins/Rplcmt Perm Dfb W/Trnsvns Lds 1/Dual Chmbr | $107,547 | $53,774 | — | — | 5 |
| J2350 | ocrelizumab per 1 mg | $104,030 | $52,015 | — | — | 5 |
| C1721 | DEFIB PROTECTA DR D334DRG DEVICE | $103,951 | $51,976 | — | — | 4 |
| J9281 | mitoMYcin 40 mg x 2 kit 1 each KIT | $95,172 | $47,586 | — | — | 5 |
| J9309 | polatuzumab vedotin-piiq per 1 mg | $93,802 | $46,901 | — | — | 10 |
| J3241 | teprotumumab per 10 mg | $90,816 | $45,408 | — | — | 5 |
| J9334 | efgartigimod-hyaluronidas-qvfc 1,008 mg-11,200 unit/5.6 mL solution 5.6 mL Vial | $81,086 | $40,543 | — | — | 5 |
| J9298 | nivolumab-relatlimab-rmbw 240-80 mg/20 mL solution 20 mL Vial | $77,727 | $38,863 | — | — | 5 |
| J9307 | pralatrexate per 1 mg | $77,305 | $38,652 | — | — | 10 |
| C1767 | HC Generator, Neurostimulator (Implantable), Nonrechargeable (Sentiva) | $75,893 | $37,947 | — | — | 4 |
| 33225 | HC Left Ventricular Lead Insertion (With Pacer/Aicd Insrt) | $75,690 | $37,845 | — | — | 4 |
| 37227 | HC Femoral Atherectomy Inc Stent Placement | $75,605 | $37,803 | — | — | 5 |
| J9026 | tarlatamab per 1 mg | $75,600 | $37,800 | — | — | 10 |
| J3357 | ustekinumab per 1 mg | $73,462 | $36,731 | — | — | 10 |
| J1628 | guselkumab per 1 mg | $73,415 | $36,707 | — | — | 5 |
| 93656 | HC Ep Ablation of Af by Pvi W/ Transseptal and Ep Evaluation | $72,205 | $36,103 | — | — | 5 |
| J9217 | leuprolide 45 mg syringe kit 1 each KIT | $64,905 | $32,453 | — | — | 5 |
| 93654 | Comp Eps W/Ablation Vt Focus | $63,930 | $31,965 | — | — | 5 |
| J9042 | brentuximab vedotin per 1 mg | $63,886 | $31,943 | — | — | 5 |
| J9043 | cabazitaxel per 1 mg | $61,113 | $30,556 | — | — | 5 |
| J9272 | dostarlimab-gxly 50 mg/mL solution 10 mL Vial | $60,633 | $30,316 | — | — | 5 |
| 36906 | HC Perc Thrombectomy & Stent(S) in Periph Segment Av Graft, Incl Pta & | $59,500 | $29,750 | — | — | 5 |
| J9022 | atezolizumab per 10 mg | $58,410 | $29,205 | — | — | 10 |
| 0795T | HC Tcat Ins Perm Dual Ldls Pm Cmpl Sys | $56,829 | $28,415 | — | — | 5 |
| 0801T | HC Ep-Dual Leadless Pacemaker Removal & Replacement | $56,315 | $28,158 | — | — | 5 |
| J2329 | ublituximab-xiiy per 1 mg | $55,994 | $27,997 | — | — | 5 |
| J9119 | cemiplimab-rwlc per 1 mg | $55,062 | $27,531 | — | — | 5 |
| 37231 | Tib/per Revasc Stent & Ather | $54,979 | $27,490 | — | — | 5 |
| 0238T | HC Trluml Perip Athrc Iliac Art | $54,979 | $27,490 | — | — | 5 |
| J2327 | risankizumab per 1 mg | $53,585 | $26,793 | — | — | 5 |
| J1744 | icatibant per 1 mg | $53,374 | $26,687 | — | — | 5 |
| J9144 | daratumumab, hyaluronidase per 10 mg | $53,282 | $26,641 | — | — | 5 |
| J3055 | talquetamab-tgvs per 0.25 mg | $52,214 | $26,107 | — | — | 10 |
| 33274 | HC Leadless Pacemaker | $51,253 | $25,627 | — | — | 5 |
| C9765 | HC Revasc of Lower Extremity With Ivl/Pta/Stent | $51,141 | $25,571 | — | — | 5 |
| C9766 | HC Revasc Ivl/Athrec/Pta | $51,141 | $25,571 | — | — | 5 |
| C9767 | HC Revasc Ivl/ Athrec/Pta/Stent | $51,141 | $25,571 | — | — | 5 |
| C9773 | HC Revasc Tib/Peroneal Ivl/Pta/Stent | $51,141 | $25,571 | — | — | 5 |
| C9774 | HC Revasc Tib/Peroneal Ivl/Athrec/Pta | $51,141 | $25,571 | — | — | 5 |
| C9775 | HC Revasc Tib/Peroneal Ivl/Athrec/Stent | $51,141 | $25,571 | — | — | 5 |
| 33206 | Atrial Ld W/Pac Inse/Repl | $50,210 | $25,105 | — | — | 5 |
Showing top 50 of 11,353 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.